Omics Gaucher Study: Multiomic Approach To Describe The Gaucher Disease Treatment Dynamics In Comparison To Untreated Healthy Volunteers
Status: Active_not_recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The study aims to investigate the transcriptomic and metabolomic changes in blood, plasma and isolated monocytes from Gaucher patients and healthy controls.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
⁃ Gaucher Type 1 participants:
• Informed consent
• The participant is older than 18 years old
• The participant was diagnosed with Gaucher Type 1 disease
⁃ Gaucher Type 3 participants:
• Informed consent
• The participant is older than 18 years old
• The participant was diagnosed with Gaucher type 3 disease
⁃ Healthy participants:
• Informed consent
• The participant is older than 18 years old
• Healthy participants
Locations
Other Locations
Germany
UKE
Hamburg
Time Frame
Start Date: 2022-10-06
Completion Date: 2025-12
Participants
Target number of participants: 25
Treatments
Gaucher Type 1
* The participant was diagnosed with Gaucher type 1 disease~* Adults only
Gaucher Type 3
* The participant was diagnosed with Gaucher type 3 disease~* Adults only
Healthy Volunteer
* Healthy participants~* Adults only
Related Therapeutic Areas
Sponsors
Leads: CENTOGENE GmbH Rostock